CN Patent
CN102281879A — 含有5-甲基-1-苯基-2-(1h)-吡啶酮的贴剂
Assigned to Lead Chemical Co Ltd · Expires 2011-12-14 · 14y expired
What this patent protects
本发明的课题是提供含有5-甲基-1-苯基-2-(1H)-吡啶酮的贴剂。作为本发明的解决课题的方法是一种含有5-甲基-1-苯基-2-(1H)-吡啶酮的贴剂,该贴剂具有含有有效药效成分的层,其特征在于,该含有有效药效成分的层含有油性基剂、溶解剂(但甘油和中链脂肪酸甘油三酯除外)和5-甲基-1-苯基-2-(1H)-吡啶酮或其医学上容许的盐类。
USPTO Abstract
本发明的课题是提供含有5-甲基-1-苯基-2-(1H)-吡啶酮的贴剂。作为本发明的解决课题的方法是一种含有5-甲基-1-苯基-2-(1H)-吡啶酮的贴剂,该贴剂具有含有有效药效成分的层,其特征在于,该含有有效药效成分的层含有油性基剂、溶解剂(但甘油和中链脂肪酸甘油三酯除外)和5-甲基-1-苯基-2-(1H)-吡啶酮或其医学上容许的盐类。
Drugs covered by this patent
- Xofluza (BALOXAVIR MARBOXIL) · Roche
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.